Hypertrophic Cardiomyopathy (HCM) is a genetic disorder that affects approximately 1 in 500 people. Some individuals with HCM don’t experience symptoms, while others can present with exertional dyspnea, fatigue, palpitations, lightheadedness, syncope, atypical chest pain, cardiac arrhythmias, or sudden cardiac death (SCD) related to ventricular diastolic dysfunction. In this series, we will review the clinical trial data about the diagnosis, genetics, and management of HCM.
Videos in the Series
Funding support provided by Bristol-Myers Squibb.
About CardioBites
CardioBites are mobile-friendly, bite-sized videos providing focused education on important topics in the heart failure field. They can be watched anytime, anywhere on YouTube. No password. No barriers. Just easy access. Each CardioBites series is designed to educate physicians, scientists, nurses, nurse practitioners, pharmacists, and patients about the recent advances and emerging trends in Heart Failure. Learn More.